Partners
Meet the organizations and people combining complementary expertise to advance TEIDe’s approach to dementia prevention.
AdventHealth Research Institute AHRI
Orlando, USA
AdventHealth Research Institute is a leading clinical research organization dedicated to advancing medical knowledge and improving patient care through innovative research. By conducting high-quality clinical trials and translational studies, the Institute collaborates with scientists, physicians, and global partners to accelerate discoveries that improve health outcomes and quality of life.
Kirk I. Erickson
Full Professor, Department of Psychology, University of Pittsburgh; Director, AdventHealth Research Institute, Neuroscience Institute
Biomedical Research Center Slovak Academy of Sciences
Bratislava, Slovakia
The Biomedical Research Center of the Slovak Academy of Sciences is a leading biomedical research institution in Slovakia, integrating basic, translational, and clinical research to address major health challenges, including neurodegenerative, metabolic, cardiovascular, and oncological diseases. It comprises the Clinical Research Unit, the Center of Physical Activity, and the Center for Obesity Management, which is accredited by the European Association for the Study of Obesity. These facilities enable the implementation of multidomain interventions within randomised controlled trials, as well as outpatient, lifestyle-based management programmes for individuals at risk of accelerated age-related cognitive decline.
By combining multidisciplinary expertise with state-of-the-art technologies and international collaborations, the Biomedical Research Center seeks to uncover the molecular, cellular, and systemic mechanisms underlying human diseases, identify novel biomarkers and therapeutic targets, and translate scientific discoveries into improved healthcare. The Center also plays a key role in educating young scientists, participating in European research initiatives, and fostering innovation to address current and future challenges in biomedical research.
Acknowledgements
Slovak partners received funding from the Slovak Academy of Sciences (TEIDe, ERA4HEALTHNUTRIBRAIN-014)
Barbara Ukropcová
Professor of Human Physiology and Pathophysiology, Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences
Fondazione Alzheimer Italia ETS (formerly Federazione Alzheimer Italia)
Milan, Italy
Fondazione Alzheimer Italia ETS is Italy’s leading national non-profit organization dedicated to improving the quality of life of people with dementia and their families. Its activities include promoting scientific research on Alzheimer’s disease and other forms of dementia, supporting people with dementia and their families, advocating for their rights, and contributing to health and social care policy. The Foundation coordinates a nationwide network of 45 associations and is the sole Italian representative of Alzheimer’s Disease International (ADI).
Through support services, training, awareness initiatives and advocacy, Alzheimer Italia works to build a more informed and inclusive society. Its initiatives include “Comunità Amiche delle Persone con Demenza” (Dementia Friendly Communities), active since 2016 and now involving more than 80 Italian cities.
Mario Possenti
Secretary General, Fondazione Alzheimer Italia ETS
ibs.GRANADA / FIBAO
Granada, Spain
The Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) is a Health Research Institute established in 2012 through a collaboration between the Regional Government of Andalusia, the University of Granada, the Andalusian Health Service and FIBAO. It brings together leading healthcare, academic and research institutions in Granada to promote high-quality biomedical and health research.
FIBAO (Fundación para la Investigación Biosanitaria de Andalucía Oriental) is the non-profit research management foundation of ibs.GRANADA. It provides comprehensive support across the biomedical research value chain, from project management and research promotion to innovation, knowledge transfer and the translation of research results into benefits for healthcare and society.
Together, ibs.GRANADA and FIBAO provide the scientific, clinical and management environment supporting research activities within the TEIDe project.
Acknowledgements
Project HOR-2025-03 is co-funded by the Consejería de Presidencia, Sanidad y Emergencias de la Junta de Andalucía.
Irene Esteban-Cornejo
Ramon y Cajal Research Assistant Professor, School of Sport Sciences, University of Granada
IMBB Institute for Mind, Brain and Behavior at the HMU Health and Medical University
Potsdam, Germany
The IMBB is an interdisciplinary research institute at HMU that investigates fundamental psychological mechanisms and neurobiological structures in humans and animals. Its research focuses on affective and cognitive processes of experience and behavior, as well as individual differences and the underlying neuroanatomical structures and their development across the lifespan. The IMBB comprises scientists from the fields of physiology, neuroscience, experimental psychology, personality research, and computational modeling/statistics.
Acknowledgements
Funded by the German Federal Ministry of Research, Technology and Space (BMFTR) under grant number 01EA2507.
Elisabeth Wenger
Professor for developmental psychology, HMU Health and Medical University, Potsdam
HOLISUN
Baia Mare, Romania
Holisun is a software research and development company, focused on innovation. With more than 25 years of experience in development, and 15 years experience in research, Holisun provides novel solutions in fields like: Smart Agriculture, Smart Logistics, Cybersecurity, Predictive Analysis and Forecasting, Critical Infrastructures, Bio Materials, and Health & Smart Medicine. We have implemented projects on programmes like FP7, Horizon 2020, Horizon Europe, ERA-NET, ICT-AGRI-FOOD, EUROSTARS, PNRR, and many more. The team consists of 2 PhD researchers, 4 PhD students and 17 masters level assistant researchers.
Acknowledgements
This work was supported by a grant of the Romanian National Authority for Scientific Research and Innovation, CCCDI – UEFISCDI, project number TEIDe – 7769/ 24.11.2025, within ERA4HEALTH.
Oliviu Matei
CEO and Founder, HOLISUN
IBIMA Plataforma BIONAND
Malaga, Spain
IBIMA Plataforma BIONAND (www.ibima.eu/) is a multidisciplinary research space in biomedicine and nanomedicine that is centred around the three largest hospitals in Malaga (Regional, Virgen de la Victoria and Costa del sol University Hospitals) and Primary Care Units of the Andalusian Public Health System, together with the biotechnological groups of the University of Malaga. This entity brings together more than 90 research groups, selected based on scientific excellence, and working on eight big research areas. IBIMA aims to promote research of excellence, oriented towards translational research, fostering transferable results to clinical practice, advancing in the improvement of prevention, diagnosis and treatment of the most prevalent health problems at the regional, national and international level. It enables the development and promotion of a space for cutting-edge research that contributes to the scientific basis of the programs and policies of the National Health System.
In 2015, IBIMA obtained recognition from the National Ministry of Health as one of the Biomedical Research Institute of reference in Spain. In 2022, the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) was integrated into IBIMA, equipped with a nanoimaging Unit holding the distinction of “Singular Scientific and Technical Infrastructure” awarded by the Spanish Government, infrastructure unique in Spain and one of the most complete in Europe.
The Institute is part of relevant European research infrastructures such us EATRIS (Biomarkers and ATMP platforms) and ECRIN (designated in 2022 as National Hub of ECRIN-ERIC by the Spanish Government) and also participates in more than 80 scientific and technological research networks, being a European reference in biomedical and translational research.
Acknowledgements
This project received funding from Instituto de Salud Carlos III (AC24/00016) under the umbrella of the Partnership Fostering a European Research Area for Health (ERA4Health) (GA No. 101095426 of the EU Horizon Europe Research and Innovation Programme).
María Rodríguez-Ayllón
Postdoctoral Researcher, IBIMA Plataforma BIONAND
The Cardiac Exercise Research Group (CERG), Norwegian University of Science and Technology (NTNU)
Trondheim, Norway
The Cardiac Exercise Research Group (CERG) at the Norwegian University of Science and Technology (NTNU) is an internationally recognized research center dedicated to advancing knowledge on the role of physical activity and exercise in the prevention and treatment of chronic disease, healthy aging, and longevity. CERG integrates basic, clinical, and population-based research, combining large longitudinal cohorts, randomized controlled trials, and mechanistic studies to investigate how exercise influences cardiovascular, metabolic, and cognitive health across the lifespan.
By bringing together multidisciplinary expertise in exercise physiology, epidemiology, medicine, molecular biology, and biostatistics, CERG develops evidence-based strategies to improve public health and clinical practice. The group has extensive experience coordinating large-scale national and international research projects and is committed to translating scientific discoveries into practical recommendations for healthcare, while also providing high-quality training for the next generation of researchers.
Dorthe Stensvold
Professor of Exercise Medicine, Norwegian University of Science and Technology (NTNU)